Filetype
Congratulations to Shelby Shrigley on nailing her thesis "Exploring Patient-Specific Cell Replacement Therapy for Parkinson's disease". The nailing took place on Friday, Feb 19th, 2021 and the defence will take place on Friday, March 12th, 2021.
https://www.regenerative-neurobiology.lu.se/article/nailing-shelby-shrigleys-thesis-successful - 2025-12-21
Congratulations to Prof. Malin Parmar, who has been elected as one of three new members of the Board of Directors at the International Society for Stem Cell Research (ISSCR). For full article please click here: https://www.stemcellcenter.lu.se/article/malin-parmar-elected-isscr-board-directors
https://www.regenerative-neurobiology.lu.se/article/malin-parmar-elected-isscr-board-directors - 2025-12-21
During her PhD studies Shelby Shrigley has been exploring patient-specific cell replacement therapy for Parkinson's disease. Defending her PhD thesis on March 12th, here Shelby tells us about her research within the Developmental and Regenerative Neurobiology research group led by Prof. Malin Parmar and her time spent at Lund Stem Cell Center. For the full interview, please click here: https://www
https://www.regenerative-neurobiology.lu.se/article/phd-defence-interview-shelby-shrigley-0 - 2025-12-21
We are very happy to congratulate Shelby Shrigley who on March 12th, 2021 successfully defended her thesis "Exploring Patient-Specific Cell Replacement Therapy for Parkinson's Disease"! To read Shelby's thesis "Exploring Patient-Specific Cell Replacement Therapy for Parkinson's Disease" OPEN ACCESS, please click here.
https://www.regenerative-neurobiology.lu.se/article/congratulations-dr-shrigley - 2025-12-21
Vinnova is Sweden's innovation agency with the mission to build Sweden’s innovation capacity. Earlier this year they announced a call for projects aiming to establish “Innovative environments for precision medicine” and last week they announced that the Lund-based project IndiCell is one of the funded projects. IndiCell is a collaborative project designed to connect academia, hospitals and industr
https://www.regenerative-neurobiology.lu.se/article/malin-parmar-anna-falk-awarded-5-year-grant-vinnova - 2025-12-21
We are very happy and proud to announce that Malin Parmar has been awarded a 10-year Distinguished professor grant from the Swedish Research Council! The aim of the distinguished professor programme is to create conditions for the most prominent researchers to conduct long-term, ground-breaking research with great potential for achieving scientific breakthroughs. The grant shall also enable the es
Läs här om ett samarbete mellan lundaforskarna Johan Jakobsson och Malin Parmar som har lett till en ny metod för att studera åldersrelaterade hjärnsjukdomar. https://www.lu.se/artikel/ny-forskningsmodell-ska-ge-svar-om-huntingtons-sjukdom
https://www.regenerative-neurobiology.lu.se/article/ny-forskningsmodell-ska-ge-svar-om-huntingtons-sjukdom - 2025-12-21
Nya ledamöter studerar Parkinsons sjukdom / New members of the class for medical sciences. For more inforamtion please click on the below links: På Svenska: https://www.kva.se/nyheter/nya-ledamoter-studerar-parkinsons-sjukdom/ Lunds universitet: https://www.medicin.lu.se/artikel/lundaprofessor-invald-i-kungliga-vetenskapsakademien In English: https://www.kva.se/en/news/new-members-of-the-class-for
https://www.regenerative-neurobiology.lu.se/article/malin-parmar-becomes-new-member-royal-swedish-academy-sciences - 2025-12-21
An international research project led from Lund University is now awarded 33 million SEK by the European Innovation Council, EIC Pathfinder. The idea behind the project is to use drugs to reprogram cancer cells into immune cells, in order to increase the body's natural anti-tumor response and fight cancer. And it is small molecules that will do the work. The research project that has received fund
https://www.medicine.lu.se/article/enemy-friend-33-million-reprogramming-cancer-cells - 2025-12-21
Cancer researcher Harald Stenmark, professor at the University of Oslo and Oslo University Hospital, is the recipient of this year’s prize. Harald Stenmark is being recognised for his groundbreaking research in cell biology, in which he has elucidated in detail the functions of proteins essential for the regulation of endosomes and cell division of significance to cancer. Harald Stenmark’s researc
https://www.medicine.lu.se/article/eric-k-fernstrom-nordic-prize-2023-awarded-cancer-researcher - 2025-12-21
How do heritability and the fetal environment affect the risk for the child to develop type 2 diabetes? This is a question that Rashmi Prasad studies in her research projects that that may lead to individualised prevention measures. She will be awarded this year’s recipient Medeon stipend on the World Diabetes Day Skåne event on November 14. Diabetes researcher Rashmi Prasad at Lund University Dia
https://www.medicine.lu.se/article/research-inherited-type-2-diabetes-awarded - 2025-12-21
David Gisselsson Nord and Tony Ingesson both love spy novels and have a nerdy interest in history. Their shared curiosity resulted in an interdisciplinary collaboration about how it might be possible to inspire smarter cancer treatment with the help of methods from espionage and intelligence analysis. Tony Ingesson finds it fairly easy to show a bit of attitude in front of the camera. David Gissel
https://www.medicine.lu.se/article/cancer-researcher-and-intelligence-expert - 2025-12-21
Breath-holding spells are common in young children and are benign. Yet children often undergo unnecessary diagnostic interventions when seeking medical care. This is because there are no national or international guidelines on how to assess children in these cases. A team of researchers at Lund University, Sweden has now proposed guidelines to reduce the number of emergency and unplanned medical v
https://www.medicine.lu.se/article/children-breath-holding-spells-undergo-unnecessary-diagnostic-interventions - 2025-12-21
Researchers have succeeded in restoring lost brain function in mouse models of stroke using small molecules that in the future could potentially be developed into a stroke therapy. “Communication between nerve cells in large parts of the brain changes after a stroke and we show that it can be partially restored with the treatment", says Tadeusz Wieloch, senior professor at Lund University who led
https://www.medicine.lu.se/article/new-study-lost-brain-function-restored-after-stroke - 2025-12-21
Intensive efforts are being made in medical research to discover the genomic causes of undiagnosed hereditary diseases. Persistent work and new technology are providing answers to several previously unsolved, enigmatic neurological disorders. Spinocerebellar ataxia type 4 was one of these, but now a research team in Lund, Sweden, have identified the gene that is responsible. Almost half a million
Christopher Douse, a new group leader at the Faculty of Medicine at Lund University, has been awarded the Ben Barres Early Career Acceleration Award by The Chan Zuckerberg Initiative. This award includes a $1.2 million grant to support his lab’s exploration of the repetitive portion of the human genome, so-called ‘genomic dark matter’, and its role in human brain development and degeneration. Repe
Through a simple, inexpensive five-minute test, one can obtain an initial indication of whether a child has ADHD or not. This is demonstrated by a research team at Lund University, connecting the changes in the cerebellum associated with ADHD to a finger-tapping test. The test can be used as a complement to existing diagnostic methods. ADHD is considered the most common neurodevelopmental disorder
https://www.medicine.lu.se/article/five-minute-test-indicate-adhd - 2025-12-21
The development of a new treatment strategy for bacterial infections and sepsis is being led by researchers at Lund University. In a study the researchers demonstrate how they, by mimicking a substance naturally present in the body, can neutralize toxic substances from bacteria and thereby mitigate harmful inflammation that could otherwise lead to sepsis. “Despite decades of research, there are cu
https://www.medicine.lu.se/article/step-closer-treatment-severe-bacterial-infections-and-sepsis - 2025-12-21
An international team of researchers has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The analysis was led by Lund University, Johns Hopkins University, and the Chinese University of Hong Kong. The study was published in Communications Medicine. Although people with type 2 diabetes are two times mo
https://www.medicine.lu.se/article/new-study-biomarkers-improve-prediction-cardiovascular-disease-type-2-diabetes-2 - 2025-12-21
Aquaporins are proteins that regulate the flow of water in and out of cells. These proteins have been found to play a role in both cancer and type 2 diabetes. Now, a research group at Lund University has succeeded in finding a drug candidate that binds to the protein, something that has been shown to affect the growth capability of leukemia cells. The study is published in PNAS. Aquaporins are wat
https://www.medicine.lu.se/article/blocks-aquaporins-thereby-inhibiting-cancer-growth - 2025-12-21
